Latest news with #Dh94
Al Etihad
17-04-2025
- Business
- Al Etihad
ADIO, DoH, and Hub71 join forces to enhance Abu Dhabi's position as global epicentre for life sciences investment
17 Apr 2025 17:53 ABU DHABI (ALETIHAD)Abu Dhabi Investment Office (ADIO) and the Department of Health – Abu Dhabi (DoH), have announced the signing of a strategic partnership with Hub71, Abu Dhabi's global tech ecosystem, to attract global venture capital investment and accelerate the growth of HealthTech and life sciences startups through the emirate's newly launched Health, Endurance, Longevity, and Medicine (HELM) by the Abu Dhabi Department of Economic Development (ADDED), ADIO and DoH, the HELM cluster was established to be a global hub for biotechnology, MedTech, and digital health innovation. The cluster is projected to contribute Dh94 billion to AbuDhabi'si economy and create 30,000 new jobs by the agreement, which was announced on the sidelines of Abu Dhabi Global Health Week (ADGHW), Hub71 will leverage its extensive venture capital partner network to showcase investment opportunities within the HELM cluster through targeted roadshows, networking engagements and dedicated promotional initiatives. ADIO will complement these efforts by providing attractive co-investment opportunities, tailored business support, and streamlined business facilitation services to attract international venture capital firms to establish and expand their operations within the will also proactively connect high-potential startups entering the HELM cluster with relevant venture capital investors, allowing startups to benefit from targeted market access. DoH will provide compliance support and optimise regulatory pathways to attract and streamline investment processes in the life sciences parties will collaborate on policy and infrastructure enhancements, aligning Abu Dhabi's life sciences ecosystem with international best practices. Regular policy reviews will ensure continuous improvement, enhancing the investor experience and reinforcing Abu Dhabi's position as a top destination for life sciences Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: 'For global investors and health innovators, Abu Dhabi offers more than a destination, it offers a launchpad. Through the HELM cluster, we are removing barriers, accelerating access, and providing the regulatory clarity and support that startups and investors need to scale faster and smarter. This partnership ensures that breakthroughs reach the patients, markets, and communities that need them most.'Badr Al-Olama, Director General of ADIO, said: 'This collaboration exemplifies Abu Dhabi's ability to accelerate high-growth sectors by creating the right environment for early-stage innovation to thrive. By partnering with the Department of Health – Abu Dhabi and Hub71, we are ensuring that promising ideas are matched with the capital, infrastructure, and regulatory clarity they need to scale. This not only reinforces Abu Dhabi's position as a leading destination for life sciences investment, it also supports the HELM cluster's mission to deliver transformative advancements in healthcare and lasting economic impact across the emirate.'Ahmad Ali Alwan, CEO of Hub71, said: 'This partnership is a compelling example of how Abu Dhabi's ecosystem is mobilising to strengthen the HELM cluster. By connecting ventures with leading capital partners and a vibrant community of innovative startups, we are enabling breakthrough solutions and contributing to the future of global healthcare and life sciences.'As the MENA region's fastest-growing startup ecosystem, Abu Dhabi witnessed $4.2 billion in exit and startup valuations by the end of 2023. The emirate saw $224 million in early-stage startup funding and more than $1 billion in overall venture capital funding between July 2021 and December 2021, DoH has supported 80 healthcare startups, accelerating transformative solutions across the healthcare spectrum. These efforts have created 926 specialised jobs, fostering economic growth, and strengthening the life sciences sector, which has achieved an impressive annual growth rate of 22 per cent. Held under the theme Towards Longevity: Redefining Health and Well-being, Abu Dhabi Global Health Week 2025 is a major government initiative from the Department of Health – Abu Dhabi and serves as a platform for innovation and collaboration within Abu Dhabi's healthcare sector. Source: Aletihad - Abu Dhabi
Al Etihad
17-04-2025
- Business
- Al Etihad
ADIO, DoH partner with Abu Dhabi Stem Cells Centre, NYU Abu Dhabi, and UAE University to advance life sciences R&D
17 Apr 2025 17:41 ABU DHABI (ALETIHAD)The Abu Dhabi Investment Office (ADIO) and the Department of Health – Abu Dhabi (DoH) have signed a strategic agreement with Abu Dhabi Stem Cells Centre (ADSCC), New York University Abu Dhabi (NYUAD) and UAE University (UAEU) to accelerate the development of the emirate's new Health, Endurance, Longevity, and Medicine (HELM) HELM cluster is a ground-breaking initiative spearheaded by the Abu Dhabi Department of Economic Development (ADDED), ADIO, and DoH that aims to position Abu Dhabi as a global hub for biotechnology, MedTech and digital health innovation. The cluster is projected to contribute more than Dh94 billion to Abu Dhabi's GDP and unlock 30,000 new jobs by during Abu Dhabi Global Health Week (ADGW), the partnership unites prominent Abu Dhabi-based research, academic, and clinical institutions to commit resources, expertise, and infrastructure to establish the HELM cluster as a pioneering innovation hub that promotes cutting-edge research and development (R&D), commercialisation, and new opportunities for growth in the academic and private Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: 'Abu Dhabi is not just investing in science, we are shaping the future of health. With the HELM cluster, we are bridging research, regulation and real-world impact to create an ecosystem where innovation thrives and transforms lives. This partnership reinforces Abu Dhabi's position as a leading global life sciences cluster, one that attracts talent, enables breakthrough discoveries, and powers a sustainable, knowledge-based economy.'As part of the agreement, all parties will work together to develop a comprehensive, clear and efficient framework to support advanced life sciences and biotechnology companies and academic institutions operating within the HELM cluster. This framework will facilitate their ability to commercialise products and services and integrate into global value chains while removing unnecessary barriers to innovation, with DoH ensuring regulatory Al-Olama, Director General of ADIO, said: 'Abu Dhabi is advancing its role as a trusted destination for innovation, creating the conditions for globally impactful research to thrive. This agreement brings together the emirate's strongest academic, clinical and regulatory institutions to build an ecosystem where medical breakthroughs can move from research to real-world application faster, and at scale. With the HELM cluster, we are creating an environment where companies can innovate with confidence, access global markets and contribute to a life sciences ecosystem that's built for the future.'All parties will share laboratory networks and research infrastructure to enhance the scope and quality of research capabilities and output across the Ahmed Ali Al Raeesi, Acting Vice Chancellor of UAEU, said: 'UAEU is the nation's flagship university, and in line with its strategic vision, it is committed to leadership, excellence and fostering knowledge that achieves a clear national impact. Collaborating with this distinguished group of experts provides us the opportunity to broaden our research excellence in key areas and prepare our students to lead the evolving medical sector.'Prof. Yendry Ventura, Chief Executive Officer of ADSCC, said: 'As a leading R&D centre in cellular therapy, ADSCC's strength lies in translating scientific discovery into real-world therapies —driven by an elite group of scientists and clinicians from bench to bedside. Through this collaboration, we are expanding our reach, deepening our partnerships and advancing Abu Dhabi's ambition to be at the forefront of medical innovation.'The collaboration also places a strong emphasis on talent development. The entities will collaborate on the development of specialised training programmes, internships, and workshops to develop local talent in the life sciences field. Collaboration between academic institutions and the private sector will further enhance the cluster, with plans to create joint degree programmes, research fellowships, and postdoctoral positions focused on human health Piano, Vice Chancellor of NYU Abu Dhabi, said: 'This partnership builds on our long-standing collaborations and sets the stage for more significant progress and breakthroughs. At NYU Abu Dhabi, we believe in the power of long-term commitments and global talent attraction and retention to drive progress in human health research and make a positive impact on the future of the UAE. Together, we're enhancing our connectivity, where ideas can grow and impact on a healthy future can take shape.'This strategic alliance marks a significant step forward in the cluster's development, further strengthening Abu Dhabi's position as a global leader in scientific innovation, healthcare advancement, and knowledge-based economic growth. Held under the theme Towards Longevity: Redefining Health and Well-being, Abu Dhabi Global Health Week 2025 is a major government initiative from Department of Health – Abu Dhabi that serves as a platform for innovation and collaboration within Abu Dhabi's healthcare sector. Source: Aletihad - Abu Dhabi
